Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Revamp Your Sepsis Bundle – Controversies with Vasopressors in Septic Shock

Posted on January 20, 2024
Sean P. Kane, PharmD, BCPS and Candice Schaper, MSN, RN, CFRN, CCRN, CEN, PHRN

Authors:
Sean P. Kane, PharmD, BCPS
Associate Professor, Pharmacy Practice and Assistant
Dean for Assessment
Rosalind Franklin University of Medicine and Science
Critical Care Pharmacist
Advocate Condell Medical Center

Candice Schaper, MSN, RN, CFRN, CCRN, CEN, PHRN
UCAN Flight Nurse
The University of Chicago Medicine


Disclosure(s):
Dr. Sean Kane and Dr. Candice Schaper has no relevant financial conflicts of interest in relation to this activity. All of the relevant financial relationships listed for this individual have been mitigated. The reviewers who contributed to this activity have nothing to disclose.

Type of Activity: Knowledge-based

Learning Objectives:

  • Explain the concept of a “maximum” dose of a vasopressor for septic shock and identify strategies to achieve goal mean arterial pressure in patients who exceed this maximum.
  • Discuss optimal sedation strategies for mechanically ventilated patients with septic shock requiring vasopressor therapy.
  • Describe risk associated with use of vasopressors through peripheral access.
  • Review risks associated with specific vasopressor agents used peripherally.
  • Describe reasonable surveillance of peripheral IV with administration of vasopressor agents and options for management of an identified extravasation event.
Target Audience: Pharmacists Fee: $10 (or $90 for all 10 courses). For C4 2023 participants who registered for the live program, please use the access code provided to you by email.
Release Date: May 16, 2023 Expiration Date: September 25, 2025
Estimated Time to Complete: 1 hour CE: 1.0 contact hours (0.1 CEUs)

Go to activity

acpe
The University of Illinois at Chicago College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity has been assigned ACPE Universal Activity Number 0016-0000-23-048-H01-P, for 1.0 contact hours (0.1 CEUs). Reading the learning objectives and faculty disclosures; participating in the entire knowledge-based activity, active learning activity, post-test and activity evaluation; estimating duration of time spent on the activity; and submitting NABP eProfile ID and MMDD are prerequisites for receiving continuing pharmacy education credits. All ACPE credit awarded to participants must be uploaded to CPE Monitor ™ within 30 days of the activity date, so pharmacists are required to provide their eProfile ID and date of birth (MMDD) at the time of the activity. Please contact pharmce@uic.edu if you do not see activity information listed within 30 days. For more information and to set up your e-Profile visit: www.MyCPEmonitor.net.

How to Earn Credit:

Participants must complete the activity as described above in the Continuing Education Statement. To answer the questions, click on your selected choice for each answer then proceed to the next question. We recommend that you print a copy of your answers before you submit them to us. Once completed, click on ‘Finish Attempt’, then click on ‘Submit All and Finish’ at the bottom of the page. Your post-test will automatically be graded. If you successfully complete the post-test, a confirmation message will appear at the top of the page underneath your grade. You will have a chance to review the correct answers and answer rationale.

Hardware/Software and Internet Requirements can be found at https://pharmacyce.uic.edu/moodle/.

Provider Contact Information:
For general information or questions,  email the Office of Continuing Education and Meeting Services at pharmce@uic.edu. Copyright © 2023– The Board of Trustees of the University of Illinois. All rights reserved. Reproduction in whole or in part without permission is prohibited. Privacy Policy

Modified on January 20, 2024